
89.06 Delayed Data As of Apr 16 | ![]() Today’s Change | 66.23 Today|||52-Week Range 92.08 | -2.38% Year-to-Date |
David Rolfe Comments on Edwards Lifesciences Apr 15 / GuruFocus News - Paid Partner Content | Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for Apr 13 / Zacks.com - Paid Partner Content |
David Rolfe's 1st-Quarter Wedgewood Funds Letter- 'The Roaring '20s' Apr 15 / GuruFocus News - Paid Partner Content | What's in Store for Edwards Lifesciences (EW) in Q1 Earnings? Apr 13 / Zacks.com - Paid Partner Content |
Flight Plan for Trading: Market Lessons from My Pilot Dad Apr 14 / Zacks.com - Paid Partner Content |
Previous close | 89.02 |
Today’s open | 86.90 |
Day’s range | 87.85 - 89.09 |
Volume | 6,863,644 |
Average volume (3 months) | 2,591,007 |
Market cap | $55.6B |
Earnings growth (last year) | -21.06% |
Earnings growth (this year) | +13.98% |
Earnings growth (next 5 years) | +13.55% |
Revenue growth (last year) | +0.88% |
P/E ratio | 68.5 |
Price/Sales | 13.14 |
Price/Book | 12.15 |
Today’s change | Today’s % change | |
---|---|---|
STESteris plc | +0.11 | +0.05% |
SNNSmith & Nephew PLC | +0.70 | +1.76% |
ISRGIntuitive Surgical | +7.85 | +0.98% |
SYKStryker Corp | +0.02 | +0.01% |
Next reporting date | April 21, 2021 |
EPS forecast (this quarter) | $0.47 |
Annual revenue (last year) | $4.4B |
Annual profit (last year) | $823.4M |
Net profit margin | 18.77% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |